Jason Coogan, Simplex Trading, joins 'Squawk on the Street' to discuss the relationship between oil and stocks, how traders ...
In a political space where silence is often mistaken for strategy and every answer is dissected for hidden intent, Simplex Chithyola Banda came across as a man determined not to be rushed into ...
Replimune has had its advanced melanoma treatment RP1 turned down by the FDA for a second time, a decision that has led the company to accuse the agency of inconsistencies in its review of the drug.
Replimune received a second FDA complete response letter for RP1 in advanced melanoma, raising questions about the viability of its oncolytic immunotherapy program. Replimune Group received a complete ...
Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such ...
Far more than a superficial epithelial problem, corneal melt is a progressive ulceration of corneal stromal tissue that can compromise the structural integrity of the eye. Corneal melt often precedes ...
Replimune disagrees with the FDA about whether the data set, upon which breakthrough therapy designation was awarded, is sufficient to allow this promising medicine to be made available to advanced ...
There is a running joke in the construction industry: projects don’t get delayed; only completion dates move faster than time itself. Having sat through more th ...
A 2026 consumer information overview addressing Herpafend ingredient safety profiles, potential drug interaction considerations, supplement claim context, and what HSV-1 and HSV-2 wellness consumers s ...
Following a series of reports exposing the large defaulters list within the PSU Banks, Union Bank of India has now rectified their Large Defaulters report list of February 2026, which says the list is ...
Geographers quibble over whether the Amazon or the Nile is the longest river in the world. It depends on where the river’s ...